Implanet has announced the signing of a distribution agreement for its JAZZ range in China as well as a technology partnership with Sanyou Medical.
Ludovic Lastennet, Implanet’s chief executive officer, said: “In continuation of the capital increase we completed with the support of Sanyou Medical, we are proud to further strengthen the strategic partnership between our two groups, this time on a commercial and technological level. The distribution agreement we signed will enable us to market our entire JAZZ range in China, the world’s largest market, and for which the regulatory files are already being initiated with the Chinese health authorities.
“On the technological side, this agreement enables us to leverage our respective expertise by jointly developing a new and innovative range of fixation systems for the Western markets. Lastly, the reconciliation we are making today with one of the largest manufacturers of medical devices in China will give us rapid access to leading technologies and know-how in the field of spinal surgery.”
The commercial agreement signed covers the distribution of Implanet’s JAZZ platform by Sanyou Medical in China. The technological alliance between Implanet and Sanyou Medical will enable the synergy of the two groups’ technological know-how and R&D in order to accelerate their product innovation policy. According to a press release, this partnership aims to jointly develop a brand-new European hybrid fixation system range, incorporating the very latest developments and innovations in the field of spine surgery.